Chen; Guoqing Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Guoqing Paul.The latest application filed is for "using catequentinib (anlotinib) combining with standard chemotherapy or immunotherapy in sequential order for the cancer treatment".

Company Profile

2.13.15

Chen; Guoqing Paul - Moorpark CA
Chen; Guoqing Paul - Westlake CA
Chen; Guoqing Paul - Westlake Village CA
CHEN; GUOQING PAUL - US
Chen, Guoqing Paul - Thousand Oaks CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Using Catequentinib (anlotinib) Combining With Standard Chemotherapy Or Immunotherapy In Sequential Order For The Cancer Treatment App 20220054475 - Chen; Guoqing Paul ; et al.	2022-02-24
Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts Grant 10,544,125 - Chen , et al. Ja	2020-01-28
Process For Preparing An Anti-cancer Agent, 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- Yl)cyclopropanamine, Its Crystalline Form And Its Salts App 20190002435 - Chen; Guoqing Paul ; et al.	2019-01-03
Fused quinoline compunds as PI3K, mTOR inhibitors Grant 10,112,945 - Chen , et al. October 30, 2	2018-10-30
Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts Grant 10,100,034 - Chen , et al. October 16, 2	2018-10-16
FUSED QUINOLINE COMPUNDS AS PI3K/mTOR INHIBITORS App 20180201613 - CHEN; GUOQING PAUL ; et al.	2018-07-19
Process For Preparing An Anti-cancer Agent, 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- Yl)cyclopropanamine, Its Crystalline Form And Its Salts App 20180002311 - Chen; Guoqing Paul ; et al.	2018-01-04
Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and its crystalline Grant 9,783,498 - Chen October 10, 2	2017-10-10
Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts Grant 9,751,859 - Chen , et al. September 5, 2	2017-09-05
Process for preparing an anti-cancer agent, 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts App 20160326138 - CHEN; GUOQING PAUL ; et al.	2016-11-10
Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and its crystalline App 20150353496 - CHEN; Guoqing Paul	2015-12-10
Compounds as c-Met kinase inhibitors Grant 8,664,244 - Chen March 4, 2	2014-03-04
Spiro substituted compounds as angiogenesis inhibitors Grant 8,513,283 - Chen August 20, 2	2013-08-20
Compounds as kinase inhibitors Grant 8,211,911 - Chen July 3, 2	2012-07-03
Spiro Substituted Compounds As Angiogenesis Inhibitors App 20120165371 - CHEN; Guoqing Paul	2012-06-28
Compounds As c-Met Kinase Inhibitors App 20120123126 - Chen; Guoqing Paul	2012-05-17
Spiro substituted compounds as angiogenesis inhibitors Grant 8,163,923 - Chen April 24, 2	2012-04-24
Spiro substituted compounds as angiogenesis inhibitors Grant 8,148,532 - Chen April 3, 2	2012-04-03
Spiro Compounds And Methods Of Use App 20110237794 - CHEN; GUOQING PAUL	2011-09-29
Spiro compounds and methods of use Grant 7,977,346 - Chen July 12, 2	2011-07-12
Compounds As Kinase Inhibitors App 20100048599 - CHEN; GUOQING PAUL	2010-02-25
Spiro Substituted Compounds As Angiogenesis Inhibitors App 20080227811 - Chen; Guoqing Paul	2008-09-18
Spiro Substituted Compounds As Angiogenesis Inhibitors App 20080227812 - Chen; Guoqing Paul	2008-09-18
Spiro compounds and methods of use App 20070167470 - Chen; Guoqing Paul	2007-07-19
Sampling vessel with elastic base App 20050123453 - Chen, Guoqing Paul	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.